SOX9 and cervical cancer: DDP-resistant cervical cancer cells were subsequently co-transfected with si-SOX9 and miR-361-3p inhibitor, exposed to 1, 2, 4, 8, 16, or 32 μg/ml DDP, and examined for cell viability and IC50 values.